MESADON 400 TABLET

Product Description

MESADON 400 TABLET is a premium-quality, Mesalazine 400mg delayed-release formulation, expertly designed for the effective treatment of ulcerative colitis and other inflammatory bowel diseases (IBD). Engineered for targeted intestinal delivery, it ensures maximum therapeutic effect with minimal systemic side effects.Trusted by gastroenterologists, this formulation is ideal for pharmaceutical distributors, hospital procurement, retail pharmacies, and bulk buyers seeking a high-demand, GI-focused medication for chronic care management.Key Benefits: Contains Mesalazine 400mg, a proven anti-inflammatory agent for IBD Delayed-release technology targets drug release directly to the colon Reduces inflammation, promotes mucosal healing, and prevents flare-ups Manufactured under WHO-GMP certified facilities ensuring global quality standards Applications: Effective in the management of ulcerative colitis, Crohns disease, and other chronic intestinal disorders Long-term maintenance therapy for patients with relapsing-remitting IBD Commonly prescribed in gastroenterology and internal medicine Why Choose MESADON 400 TABLET? High patient compliance with once/twice daily dosing Reliable supply chain support for bulk orders and B2B distribution Attractive margins for traders, exporters, and hospital suppliers